Literature DB >> 21258808

Current concepts in the management of stroke in children with sickle cell disease.

M S Islam1, P Anoop.   

Abstract

Stroke is the most significant complication of sickle cell disease (SCD) in children with the potential for major morbidity and mortality. The recent two decades have witnessed tremendous advancements in understanding the pathophysiology of stroke, risk stratification of children and the role of timely preventative interventions. The aetiopathogenesis, types of stroke and specific risk factors are reviewed here with special emphasis on the role of transcranial Doppler ultrasonogram in the early identification of at-risk children. Published studies on primary and secondary prevention of stroke in children with SCD are analysed with respect to the levels of evidence, in favour of preventative and therapeutic strategies. The roles of the neurologist and the neurosurgeon are highlighted.

Entities:  

Mesh:

Year:  2011        PMID: 21258808     DOI: 10.1007/s00381-011-1394-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  37 in total

1.  Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis.

Authors:  P J Nietert; M R Abboud; M D Silverstein; S M Jackson
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

2.  Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Authors:  S Charache; F B Barton; R D Moore; M L Terrin; M H Steinberg; G J Dover; S K Ballas; R P McMahon; O Castro; E P Orringer
Journal:  Medicine (Baltimore)       Date:  1996-11       Impact factor: 1.889

3.  Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease.

Authors:  Charles H Pegelow; Eric A Macklin; Franklin G Moser; Winfred C Wang; Jacqueline A Bello; Scott T Miller; Elliott P Vichinsky; Michael R DeBaun; Ludovico Guarini; Robert A Zimmerman; Donald P Younkin; Dianne M Gallagher; Thomas R Kinney
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

Review 4.  Pathophysiology and treatment of stroke in sickle-cell disease: present and future.

Authors:  Jeffrey A Switzer; David C Hess; Fenwick T Nichols; Robert J Adams
Journal:  Lancet Neurol       Date:  2006-06       Impact factor: 44.182

5.  Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease.

Authors:  Robert J Adams; Donald Brambilla
Journal:  N Engl J Med       Date:  2005-12-29       Impact factor: 91.245

6.  Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler.

Authors:  R J Adams; V C McKie; E M Carl; F T Nichols; R Perry; K Brock; K McKie; R Figueroa; M Litaker; S Weiner; D Brambilla
Journal:  Ann Neurol       Date:  1997-11       Impact factor: 10.422

7.  Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids.

Authors:  John J Strouse; Monica L Hulbert; Michael R DeBaun; Lori C Jordan; James F Casella
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

Review 8.  Therapy insight: stroke risk and its management in patients with sickle cell disease.

Authors:  Fenella J Kirkham
Journal:  Nat Clin Pract Neurol       Date:  2007-05

9.  Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage.

Authors:  J Broderick; G T Talbot; E Prenger; A Leach; T Brott
Journal:  J Child Neurol       Date:  1993-07       Impact factor: 1.987

10.  Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells.

Authors:  N C Adragna; P Fonseca; P K Lauf
Journal:  Blood       Date:  1994-01-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.